{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T15:41:54Z","timestamp":1791819714287,"version":"4.3.4"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T00:00:00Z","timestamp":1679011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T00:00:00Z","timestamp":1679011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Regional Diagnosis and Treatment Centre of the Health Planning Committee","award":["JBZX-201903"],"award-info":[{"award-number":["JBZX-201903"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31971371"],"award-info":[{"award-number":["31971371"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Science and Technology Plan Project of Jinhua","award":["2021-4-165"],"award-info":[{"award-number":["2021-4-165"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gastric Cancer"],"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Peritoneal metastasis (PM) frequently occurs in patients with gastric cancer (GC) and is a major cause of mortality. Risk stratification for PM can optimize decision making in GC treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 25 GC patients (13 with synchronous, 6 with metachronous PM and 6 PM-free) were included in this study. Quantitative proteomics by high-depth tandem mass tags labeling and whole-exome sequencing were conducted in primary GC and PM samples. Proteomic signature and prognostic model were established by machine learning algorithms in PM and PM-free GC, then validated in two external cohorts. Tumor-infiltrating immune cells in GC were analyzed by CIBERSORT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Heterogeneity between paired primary and PM samples was observed at both genomic and proteomic levels. Compared to primary GC, proteome of PM samples was enriched in RNA binding and extracellular exosomes. 641 differently expressed proteins (DEPs) between primary GC of PM group and PM-free group were screened, which were enriched in extracellular exosome and cell adhesion pathways. Subsequently, a ten-protein signature was derived based on DEPs by machine learning. This signature was significantly associated with patient prognosis in internal cohort and two external proteomic datasets of diffuse and mixed type GC. Tumor-infiltrating immune cell analysis showed that the signature was associated with immune microenvironment of GC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We characterized proteomic features that were informative for PM progression of GC. A protein signature associated with immune microenvironment and patient outcome was derived, and it could guide risk stratification and individualized treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10120-023-01379-0","type":"journal-article","created":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T04:02:46Z","timestamp":1679025766000},"page":"504-516","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Proteomic profiling of gastric cancer with peritoneal metastasis identifies a protein signature associated with immune microenvironment and patient outcome"],"prefix":"10.1007","volume":"26","author":[{"given":"Yanyan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoxin","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiran","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongfeng","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanghao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6470-9017","authenticated-orcid":false,"given":"Lisong","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,17]]},"reference":[{"issue":"8","key":"1379_CR1","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1002\/ijc.31937","volume":"144","author":"J Ferlay","year":"2019","unstructured":"Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Pineros M, Znaor A, Bray F. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144(8):1941\u201353.","journal-title":"Int J Cancer"},{"issue":"1","key":"1379_CR2","doi-asserted-by":"publisher","first-page":"149","DOI":"10.21037\/tcr.2017.01.13","volume":"6","author":"J Wei","year":"2017","unstructured":"Wei J, Yang Y, Du J, Zou Z, Zhang Y, Wu N, Wang Q, Yuan L, Liu B. Peritoneal metastasis in relation to outcome and therapeutic strategy in gastric cancer. Transl Cancer Res. 2017;6(1):149\u201356.","journal-title":"Transl Cancer Res"},{"issue":"8","key":"1379_CR3","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.3390\/cancers12082236","volume":"12","author":"Y Chen","year":"2020","unstructured":"Chen Y, Zhou Q, Wang H, Zhuo W, Ding Y, Lu J, Wu G, Xu N, Teng L. Predicting peritoneal dissemination of gastric cancer in the era of precision medicine: molecular characterization and biomarkers. Cancers (Basel). 2020;12(8):2236-55.","journal-title":"Cancers (Basel)"},{"issue":"9","key":"1379_CR4","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1245\/s10434-017-5838-y","volume":"24","author":"N Ikoma","year":"2017","unstructured":"Ikoma N, Chen HC, Wang X, Blum M, Estrella JS, Fournier K, Mansfield P, Ajani J, Badgwell BD. Patterns of initial recurrence in gastric adenocarcinoma in the era of preoperative therapy. Ann Surg Oncol. 2017;24(9):2679\u201387.","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"1379_CR5","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.1245\/s10434-021-11316-z","volume":"29","author":"J-F Zhang","year":"2022","unstructured":"Zhang J-F, Lv L, Zhao S, Zhou Q, Jiang C-G. Hyperthermic intraperitoneal chemotherapy (HIPEC) combined with surgery: a 12-year meta-analysis of this promising treatment strategy for advanced gastric cancer at different stages. Ann Surg Oncol. 2022;29(5):3170\u201386.","journal-title":"Ann Surg Oncol"},{"key":"1379_CR6","doi-asserted-by":"crossref","unstructured":"Cancer Genome Atlas Research N: Comprehensive molecular characterization of gastric adenocarcinoma. Nature 2014;513(7517):202\u20139.","DOI":"10.1038\/nature13480"},{"issue":"6","key":"1379_CR7","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1007\/s10120-021-01201-9","volume":"24","author":"H Wang","year":"2021","unstructured":"Wang H, Ding Y, Chen Y, Jiang J, Chen Y, Lu J, et al. A novel genomic classification system of gastric cancer via integrating multidimensional genomic characteristics. Gastric Cancer. 2021;24(6):1227\u201341.","journal-title":"Gastric Cancer"},{"issue":"1","key":"1379_CR8","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1158\/2159-8290.CD-17-0395","volume":"8","author":"E Pectasides","year":"2018","unstructured":"Pectasides E, Stachler MD, Derks S, Liu Y, Maron S, Islam M, et al. Genomic heterogeneity as a barrier to precision medicine in gastroesophageal adenocarcinoma. Cancer Discov. 2018;8(1):37\u201348.","journal-title":"Cancer Discov"},{"issue":"1","key":"1379_CR9","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1038\/s41467-018-03121-2","volume":"9","author":"S Ge","year":"2018","unstructured":"Ge S, Xia X, Ding C, Zhen B, Zhou Q, Feng J, et al. A proteomic landscape of diffuse-type gastric cancer. Nat Commun. 2018;9(1):1012.","journal-title":"Nat Commun"},{"key":"1379_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103714","volume":"74","author":"X Li","year":"2021","unstructured":"Li X, Zheng NR, Wang LH, Li ZW, Liu ZC, Fan H, et al. Proteomic profiling identifies signatures associated with progression of precancerous gastric lesions and risk of early gastric cancer. EBioMedicine. 2021;74: 103714.","journal-title":"EBioMedicine"},{"issue":"1","key":"1379_CR11","doi-asserted-by":"publisher","first-page":"5723","DOI":"10.1038\/s41467-022-33282-0","volume":"13","author":"Y Li","year":"2022","unstructured":"Li Y, Xu C, Wang B, Xu F, Ma F, Qu Y, et al. Proteomic characterization of gastric cancer response to chemotherapy and targeted therapy reveals new therapeutic strategies. Nat Commun. 2022;13(1):5723.","journal-title":"Nat Commun"},{"issue":"10251","key":"1379_CR12","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","volume":"396","author":"EC Smyth","year":"2020","unstructured":"Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric cancer. Lancet. 2020;396(10251):635\u201348.","journal-title":"Lancet"},{"issue":"9","key":"1379_CR13","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1038\/s41591-018-0101-z","volume":"24","author":"ST Kim","year":"2018","unstructured":"Kim ST, Cristescu R, Bass AJ, Kim KM, Odegaard JI, Kim K, et al. Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer. Nat Med. 2018;24(9):1449\u201358.","journal-title":"Nat Med"},{"issue":"6","key":"1379_CR14","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1038\/s41416-020-0975-7","volume":"123","author":"T Hagi","year":"2020","unstructured":"Hagi T, Kurokawa Y, Kawabata R, Omori T, Matsuyama J, Fujitani K, et al. Multicentre biomarker cohort study on the efficacy of nivolumab treatment for gastric cancer. Br J Cancer. 2020;123(6):965\u201372.","journal-title":"Br J Cancer"},{"issue":"10111","key":"1379_CR15","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1016\/S0140-6736(17)31827-5","volume":"390","author":"YK Kang","year":"2017","unstructured":"Kang YK, Boku N, Satoh T, Ryu MH, Chao Y, Kato K, et al. Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2017;390(10111):2461\u201371.","journal-title":"Lancet"},{"key":"1379_CR16","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.canlet.2019.11.009","volume":"470","author":"X Lei","year":"2020","unstructured":"Lei X, Lei Y, Li JK, Du WX, Li RG, Yang J, Li J, Li F, Tan HB. Immune cells within the tumor microenvironment: Biological functions and roles in cancer immunotherapy. Cancer Lett. 2020;470:126\u201333.","journal-title":"Cancer Lett"},{"issue":"14","key":"1379_CR17","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Durbin R. Fast and accurate short read alignment with burrows-wheeler transform. Bioinformatics. 2009;25(14):1754\u201360.","journal-title":"Bioinformatics"},{"issue":"12","key":"1379_CR18","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1093\/bioinformatics\/btv098","volume":"31","author":"A Tarasov","year":"2015","unstructured":"Tarasov A, Vilella AJ, Cuppen E, Nijman IJ, Prins P. Sambamba: fast processing of NGS alignment formats. Bioinformatics. 2015;31(12):2032\u20134.","journal-title":"Bioinformatics"},{"issue":"16","key":"1379_CR19","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkq603","volume":"38","author":"K Wang","year":"2010","unstructured":"Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010;38(16): e164.","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"1379_CR20","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.cell.2016.05.069","volume":"166","author":"H Zhang","year":"2016","unstructured":"Zhang H, Liu T, Zhang Z, Payne SH, Zhang B, McDermott JE, et al. Integrated proteogenomic characterization of human high-grade serous ovarian cancer. Cell. 2016;166(3):755\u201365.","journal-title":"Cell"},{"issue":"4","key":"1379_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1004873","volume":"12","author":"E Talevich","year":"2016","unstructured":"Talevich E, Shain AH, Botton T, Bastian BC. CNVkit: genome-wide copy number detection and visualization from targeted DNA sequencing. PLoS Comput Biol. 2016;12(4): e1004873.","journal-title":"PLoS Comput Biol"},{"issue":"4","key":"1379_CR22","doi-asserted-by":"publisher","first-page":"R41","DOI":"10.1186\/gb-2011-12-4-r41","volume":"12","author":"CH Mermel","year":"2011","unstructured":"Mermel CH, Schumacher SE, Hill B, Meyerson ML, Beroukhim R, Getz G. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol. 2011;12(4):R41.","journal-title":"Genome Biol"},{"issue":"8","key":"1379_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1003665","volume":"10","author":"CA Miller","year":"2014","unstructured":"Miller CA, White BS, Dees ND, Griffith M, Welch JS, Griffith OL, et al. SciClone: inferring clonal architecture and tracking the spatial and temporal patterns of tumor evolution. PLoS Comput Biol. 2014;10(8): e1003665.","journal-title":"PLoS Comput Biol"},{"issue":"1","key":"1379_CR24","doi-asserted-by":"publisher","first-page":"20560","DOI":"10.1038\/s41598-020-76603-3","volume":"10","author":"J Goedhart","year":"2020","unstructured":"Goedhart J, Luijsterburg MS. VolcaNoseR is a web app for creating, exploring, labeling and sharing volcano plots. Sci Rep. 2020;10(1):20560.","journal-title":"Sci Rep"},{"issue":"21","key":"1379_CR25","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1093\/bioinformatics\/bts515","volume":"28","author":"J Feng","year":"2012","unstructured":"Feng J, Meyer CA, Wang Q, Liu JS, Shirley Liu X, Zhang Y. GFOLD: a generalized fold change for ranking differentially expressed genes from RNA-seq data. Bioinformatics. 2012;28(21):2782\u20138.","journal-title":"Bioinformatics"},{"key":"1379_CR26","doi-asserted-by":"crossref","unstructured":"Cai G, Zhou Z, Gu X: MATTE: anti-noise module alignedment for phenotype-gene-related. bioRxiv 2022(2022.05.29.493935).","DOI":"10.1101\/2022.05.29.493935"},{"issue":"5","key":"1379_CR27","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/nm.3850","volume":"21","author":"R Cristescu","year":"2015","unstructured":"Cristescu R, Lee J, Nebozhyn M, Kim KM, Ting JC, Wong SS, et al. Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes. Nat Med. 2015;21(5):449\u201356.","journal-title":"Nat Med"},{"key":"1379_CR28","doi-asserted-by":"crossref","unstructured":"Chen T, Guestrin C XGBoost: a scalable tree boosting system. Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining 2016:785\u201394.","DOI":"10.1145\/2939672.2939785"},{"key":"1379_CR29","first-page":"2825","volume":"12","author":"F Pedregosa","year":"2011","unstructured":"Pedregosa F, Varoquaux G, Gramfort A, Michel V, Thirion B, Grisel O, Blondel M. Scikit-learn: machine learning in python. J Mach Learn Res. 2011;12:2825\u201330.","journal-title":"J Mach Learn Res"},{"issue":"W1","key":"1379_CR30","doi-asserted-by":"publisher","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","volume":"48","author":"T Li","year":"2020","unstructured":"Li T, Fu J, Zeng Z, Cohen D, Li J, Chen Q, Li B, Liu XS. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 2020;48(W1):W509\u201314.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"1379_CR31","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman AM, Liu CL, Green MR, Gentles AJ, Feng W, Xu Y, Hoang CD, Diehn M, Alizadeh AA. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453\u20137.","journal-title":"Nat Methods"},{"issue":"1","key":"1379_CR32","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1097\/SLA.0000000000002040","volume":"267","author":"JH Lee","year":"2018","unstructured":"Lee JH, Chang KK, Yoon C, Tang LH, Strong VE, Yoon SS. Lauren histologic type is the most important factor associated with pattern of recurrence following resection of gastric adenocarcinoma. Ann Surg. 2018;267(1):105\u201313.","journal-title":"Ann Surg"},{"issue":"1","key":"1379_CR33","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1136\/gutjnl-2018-318070","volume":"69","author":"R Wang","year":"2020","unstructured":"Wang R, Song S, Harada K, Ghazanfari Amlashi F, Badgwell B, Pizzi MP, et al. Multiplex profiling of peritoneal metastases from gastric adenocarcinoma identified novel targets and molecular subtypes that predict treatment response. Gut. 2020;69(1):18\u201331.","journal-title":"Gut"},{"issue":"1","key":"1379_CR34","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41591-020-1125-8","volume":"27","author":"R Wang","year":"2021","unstructured":"Wang R, Dang M, Harada K, Han G, Wang F, Pool Pizzi M, et al. Single-cell dissection of intratumoral heterogeneity and lineage diversity in metastatic gastric adenocarcinoma. Nat Med. 2021;27(1):141\u201351.","journal-title":"Nat Med"},{"issue":"9","key":"1379_CR35","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1038\/s43018-021-00240-6","volume":"2","author":"Y Tanaka","year":"2021","unstructured":"Tanaka Y, Chiwaki F, Kojima S, Kawazu M, Komatsu M, Ueno T, et al. Multi-omic profiling of peritoneal metastases in gastric cancer identifies molecular subtypes and therapeutic vulnerabilities. Nat Cancer. 2021;2(9):962\u201377.","journal-title":"Nat Cancer"},{"key":"1379_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.684871","volume":"11","author":"X Chen","year":"2021","unstructured":"Chen X, Wang H, Huang Y, Chen Y, Chen C, Zhuo W, Teng L. Comprehensive roles and future perspectives of exosomes in peritoneal metastasis of gastric cancer. Front Oncol. 2021;11: 684871.","journal-title":"Front Oncol"},{"key":"1379_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2021.110046","volume":"85","author":"YG Mishra","year":"2021","unstructured":"Mishra YG, Manavathi B. Focal adhesion dynamics in cellular function and disease. Cell Signal. 2021;85: 110046.","journal-title":"Cell Signal"},{"issue":"1","key":"1379_CR38","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ccell.2018.12.003","volume":"35","author":"D-G Mun","year":"2019","unstructured":"Mun D-G, Bhin J, Kim S, Kim H, Jung JH, Jung Y, et al. Proteogenomic characterization of human early-onset gastric cancer. Cancer Cell. 2019;35(1):111-24.e10.","journal-title":"Cancer Cell"},{"key":"1379_CR39","doi-asserted-by":"publisher","first-page":"13568","DOI":"10.1038\/ncomms13568","volume":"7","author":"XY Ming","year":"2016","unstructured":"Ming XY, Fu L, Zhang LY, Qin YR, Cao TT, Chan KW, Ma S, Xie D, Guan XY. Integrin alpha7 is a functional cancer stem cell surface marker in oesophageal squamous cell carcinoma. Nat Commun. 2016;7:13568.","journal-title":"Nat Commun"},{"key":"1379_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2019.109465","volume":"66","author":"JC Ge","year":"2020","unstructured":"Ge JC, Wang YX, Chen ZB, Chen DF. Integrin alpha 7 correlates with poor clinical outcomes, and it regulates cell proliferation, apoptosis and stemness via PTK2-PI3K-Akt signaling pathway in hepatocellular carcinoma. Cell Signal. 2020;66: 109465.","journal-title":"Cell Signal"},{"issue":"9","key":"1379_CR41","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.4049\/jimmunol.1800469","volume":"203","author":"Y Wu","year":"2019","unstructured":"Wu Y, Konate MM, Lu J, Makhlouf H, Chuaqui R, Antony S, et al. IL-4 and IL-17A cooperatively promote hydrogen peroxide production, oxidative DNA damage, and upregulation of dual oxidase 2 in human colon and pancreatic cancer cells. J Immunol. 2019;203(9):2532\u201344.","journal-title":"J Immunol"},{"issue":"1","key":"1379_CR42","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1093\/carcin\/bgaa056","volume":"42","author":"X Zhang","year":"2021","unstructured":"Zhang X, Han J, Feng L, Zhi L, Jiang D, Yu B, et al. DUOX2 promotes the progression of colorectal cancer cells by regulating the AKT pathway and interacting with RPL3. Carcinogenesis. 2021;42(1):105\u201317.","journal-title":"Carcinogenesis"},{"issue":"5","key":"1379_CR43","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/nm.4323","volume":"23","author":"AP Morel","year":"2017","unstructured":"Morel AP, Ginestier C, Pommier RM, Cabaud O, Ruiz E, Wicinski J, et al. A stemness-related ZEB1-MSRB3 axis governs cellular pliancy and breast cancer genome stability. Nat Med. 2017;23(5):568\u201378.","journal-title":"Nat Med"},{"issue":"4","key":"1379_CR44","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.21037\/tlcr-19-701","volume":"9","author":"Y Wu","year":"2020","unstructured":"Wu Y, Li L, Wang Q, Zhang L, He C, Wang X, Liu H. LINC00511 promotes lung squamous cell carcinoma proliferation and migration via inhibiting miR-150-5p and activating TADA1. Transl Lung Cancer Res. 2020;9(4):1138\u201348.","journal-title":"Transl Lung Cancer Res"},{"key":"1379_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.828373","volume":"13","author":"X Jiang","year":"2022","unstructured":"Jiang X, Yang L, Gao Q, Liu Y, Feng X, Ye S, Yang Z. The role of RAB GTPases and its potential in predicting immunotherapy response and prognosis in colorectal cancer. Front Genet. 2022;13: 828373.","journal-title":"Front Genet"},{"issue":"6","key":"1379_CR46","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41417-019-0118-6","volume":"27","author":"L Zhao","year":"2020","unstructured":"Zhao L, Xue M, Zhang L, Guo B, Qin Y, Jiang Q, et al. MicroRNA-4268 inhibits cell proliferation via AKT\/JNK signalling pathways by targeting Rab6B in human gastric cancer. Cancer Gene Ther. 2020;27(6):461\u201372.","journal-title":"Cancer Gene Ther"},{"key":"1379_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.890154","volume":"12","author":"D Zhang","year":"2022","unstructured":"Zhang D, Lindstrom A, Kim EJ, Hwang CI, Hall ML, Lin TY, Li Y. SEMA3C supports pancreatic cancer progression by regulating the autophagy process and tumor immune microenvironment. Front Oncol. 2022;12: 890154.","journal-title":"Front Oncol"},{"issue":"5","key":"1379_CR48","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.7150\/ijbs.68992","volume":"18","author":"T Lu","year":"2022","unstructured":"Lu T, Li Y, Pan M, Yu D, Wang Z, Liu C, Hu G. TBC1D14 inhibits autophagy to suppress lymph node metastasis in head and neck squamous cell carcinoma by downregulating macrophage erythroblast attacher. Int J Biol Sci. 2022;18(5):1795\u2013812.","journal-title":"Int J Biol Sci"},{"key":"1379_CR49","doi-asserted-by":"publisher","first-page":"784","DOI":"10.3389\/fimmu.2020.00784","volume":"11","author":"F Petitprez","year":"2020","unstructured":"Petitprez F, Meylan M, de Reynies A, Sautes-Fridman C, Fridman WH. The tumor microenvironment in the response to immune checkpoint blockade therapies. Front Immunol. 2020;11:784.","journal-title":"Front Immunol"},{"key":"1379_CR50","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.3389\/fimmu.2019.02368","volume":"10","author":"L Ye","year":"2019","unstructured":"Ye L, Zhang T, Kang Z, Guo G, Sun Y, Lin K, et al. Tumor-infiltrating immune cells act as a marker for prognosis in colorectal cancer. Front Immunol. 2019;10:2368.","journal-title":"Front Immunol"},{"key":"1379_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.522015","volume":"10","author":"S Xie","year":"2020","unstructured":"Xie S, Mo P, Li N, Cai W, Ruan J, Ye J, Mao J. Tumor-infiltrating lymphocyte-based risk score for predicting prognosis in gastric cancer. Front Oncol. 2020;10: 522015.","journal-title":"Front Oncol"},{"key":"1379_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.711433","volume":"12","author":"Q Xu","year":"2021","unstructured":"Xu Q, Chen S, Hu Y, Huang W. Landscape of immune microenvironment under immune cell infiltration pattern in breast cancer. Front Immunol. 2021;12: 711433.","journal-title":"Front Immunol"},{"issue":"4","key":"1379_CR53","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1158\/2159-8290.CD-21-0888","volume":"12","author":"R Kim","year":"2022","unstructured":"Kim R, An M, Lee H, Mehta A, Heo YJ, Kim KM, et al. Early tumor-immune microenvironmental remodeling and response to first-line fluoropyrimidine and platinum chemotherapy in advanced gastric cancer. Cancer Discov. 2022;12(4):984\u20131001.","journal-title":"Cancer Discov"}],"container-title":["Gastric Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10120-023-01379-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10120-023-01379-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10120-023-01379-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T12:05:33Z","timestamp":1687349133000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10120-023-01379-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,17]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["1379"],"URL":"https:\/\/doi.org\/10.1007\/s10120-023-01379-0","relation":{},"ISSN":["1436-3291","1436-3305"],"issn-type":[{"value":"1436-3291","type":"print"},{"value":"1436-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,17]]},"assertion":[{"value":"15 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}